Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Celiac disease and multiple sclerosis in the northwest of Iran.
Reproductive issues in women with multiple sclerosis: ethical considerations.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Drugs to be Discontinued
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
ATX-MS-1467 - Positive Immunological data in Multiple Sclerosis: Final Phase I/IIa data shows safety and tolerability, plus efficacy
Imaging In The Cell
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Psoriasis during natalizumab treatment for multiple sclerosis.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.

Pages